Pancreatic Cancer Research

ResearcherThe Cancer Institute HospitalActive in the last 2 years

Yu Takahashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3066-9501; OpenAlex author ID A5079456672. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2025: 2 papers · 2026: 1 paper

Papers 3

  1. Surgical Challenges Associated with Collateral Veins Formation in Pancreatic Cancer with Vein Resection. Last author DOI 10.1245/s10434-025-18806-4↗
  2. Resectable Pancreatic Cancer with CA19-9 > 500 U/mL: A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy. Last author DOI 10.1245/s10434-025-17407-5↗
  3. ASO Author Reflections: Optimizing Treatment for Resectable Pancreatic Cancer: CA19-9 > 500 U/mL as a Biologic Indicator for Neoadjuvant Therapy. Last author DOI 10.1245/s10434-025-17458-8↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aya Maekawa · 3 shared papers, 2025–2026 · strength 0.71
  2. Atsushi Oba · 3 shared papers, 2025–2026 · strength 0.71
  3. Hiromichi Ito · 3 shared papers, 2025–2026 · strength 0.71
  4. Yoshihiro Ono · 2 shared papers, 2025 · strength 0.47
  5. Yosuke Inoue · 2 shared papers, 2025 · strength 0.47
  6. Takafumi Mie · 2 shared papers, 2025 · strength 0.47
  7. Kojiro Omiya · 2 shared papers, 2025 · strength 0.47
  8. Masato Ozaka · 2 shared papers, 2025–2026 · strength 0.46
  9. Naoki Sasahira · 2 shared papers, 2025–2026 · strength 0.46
  10. Takashi Sasaki · 1 shared paper, 2026 · strength 0.24
  11. Yoshihiro Ono · 1 shared paper, 2026 · strength 0.24
  12. Yosuke Inoue · 1 shared paper, 2026 · strength 0.24
  13. Tatsunori Miyata · 1 shared paper, 2026 · strength 0.24
  14. Tomotaka Kato · 1 shared paper, 2026 · strength 0.24
  15. Masaaki Iwatsuki · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.